Blair William & Co. IL Cuts Holdings in Ralliant Corporation $RAL

Blair William & Co. IL reduced its holdings in Ralliant Corporation (NYSE:RAL) by 28.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,645 shares of the company’s stock after selling 24,259 shares during the quarter. Blair William & Co. IL owned about 0.05% of Ralliant worth $2,652,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Envestnet Asset Management Inc. acquired a new stake in Ralliant in the second quarter valued at $4,922,000. Bank of New York Mellon Corp acquired a new position in shares of Ralliant during the 2nd quarter worth $32,655,000. Savant Capital LLC purchased a new position in shares of Ralliant in the 2nd quarter valued at about $410,000. Metis Global Partners LLC purchased a new position in Ralliant in the second quarter valued at about $633,000. Finally, Aviva PLC purchased a new position in Ralliant in the second quarter valued at about $4,241,000.

Insider Buying and Selling

In related news, SVP Karen M. Bick sold 5,485 shares of the stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $45.00, for a total transaction of $246,825.00. Following the sale, the senior vice president owned 46,756 shares of the company’s stock, valued at $2,104,020. This trade represents a 10.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The shares were bought at an average price of $41.25 per share, with a total value of $82,500.00. Following the transaction, the director owned 5,403 shares in the company, valued at $222,873.75. This represents a 58.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 8,145 shares of company stock valued at $332,233.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Barclays decreased their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research note on Monday, February 9th. Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Truist Financial decreased their target price on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Friday, February 6th. Finally, Oppenheimer dropped their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Ralliant presently has a consensus rating of “Hold” and an average price target of $50.50.

Ralliant Stock Down 6.6%

RAL stock opened at $42.77 on Friday. The company’s 50 day simple moving average is $48.42 and its 200-day simple moving average is $46.69. The firm has a market capitalization of $4.78 billion and a PE ratio of 21.82. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The business’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.